News Center

Home page

Peak Report

News reports

Experience of year-end chat in Jinhua, a pharmaceutical sales company

Release time:

2021-01-21

Pharmaceutical Sales Company Jinhua Office Year-end Chat Experience

Editor's Note:# At the end of the year and the beginning of the year, the Jinhua Office of Pharmaceutical Sales Company organized the salesman to write an annual summary, talk about one year's work and share experiences. This newspaper has excerpted some of them.

Chen Yanguo

Looking back on the past year, I couldn't help feeling deeply touched. There was no vigorous success, but it was also an extraordinary test and sharpening.

2020

was a tough year, from the beginning of the year when the Paroxetine national collection dropped the mark, the new crown epidemic caused the work not to be carried out well until the second quarter to really get to work. However, 2020 is also a brilliant year. My Jinhua Office has completed all sales tasks with everyone's efforts. My personal sales have also increased compared with last year.

Sales is actually a process, including preparation before the visit, visit, and follow-up after the visit. The work of our medical representatives is not like ordinary sales. After the first sales transaction, we have to achieve long-term cooperation, from the first drug to the second-line drug, conventional drug or even recommended drug. Therefore, the follow-up work after our visit has become the focus of our daily work. I feel that in the future follow-up, I should focus on strengthening friendship and building trust, and strive to establish a lasting partnership. Timely follow-up, uninterrupted follow-up visits, let the doctor feel their dedication and respect for him.

At the same time, as a medical representative, we are dealing with highly educated doctors with extensive clinical experience. Therefore, we must continue to learn, improve our professionalism, and create a peer-to-peer platform to communicate with customers.

Shao Junli

Time passed quickly. In a twinkling of an eye, 2020 has passed. In this year, with the support and help of the company's leaders and office managers, combined with my own efforts, I have achieved relatively good results in my work.

I would like to mention again the work done when olopatadine eye drops entered Lanxi Hospital of Traditional Chinese Medicine. Olopatadine Eye Drops is a product for the treatment of allergic conjunctivitis and a blockbuster product of the Pharmaceutical Company in 2020. In July, I greeted the ophthalmologist of the hospital and hoped to help make a report. Because the company's glass eye has been sold in the hospital of traditional Chinese medicine, all the doctors in the ophthalmology department and I have kept visiting frequently, and everyone has great trust in our company's products. At the end of September, Olo was able to enter the hospital. I went to the director of the pharmacy building and showed her our product brochure to tell her the advantages of our products, but the director of the pharmacy department rejected it on the grounds that the price was too high and was unable to enter the hospital. However, I did not give up. Through repeated efforts, the director of the building was finally moved by my sincerity and agreed to go to Tseolo. After a month and a half, I finally successfully developed Olo into Lanxi Hospital of Traditional Chinese Medicine. After this incident, I also realized that as long as the effort is deep, any difficulty can be overcome, and we must have the spirit of perseverance to do a thing successfully.

In the face of the increase or decrease of the national collection and medical insurance catalogue, we medical personnel have gone through tests again and again, but we must face the difficulties. Because we always have to face the difficulties first before we can ride the waves later. We will certainly be able to break through the difficulties, through the winter, ushered in the spring. Looking forward to better 2021.

Zhou Yanqiu

2020

is fleeting. Looking back on this year's work, there are both melancholy and fruitful joy.

2020

is a special year, the new crown epidemic caused by the sudden decline in the foreign population, Yiwu at the beginning of the product catalog adjustment, with volume procurement, three major reasons to the market has brought a considerable impact. I'm a little overwhelmed by the marked decline in market sales. We can't do anything about natural disasters and policies, but the task still needs to be completed. What should we do?

Through communication with leaders and discussions among colleagues, we finally feel that only by refining the existing market and developing new markets can we increase sales. Large hospitals will develop departments that can be used in place, health centers will lay out all the following service stations in place, and newly developed customers will be trained quietly to become VIP. At the same time to develop ophthalmology, increase the sales of new products, walk on two legs, take every step seriously.

Sales is a good training in life. If you want to do a good job in sales, I personally think you must have a high comprehensive ability and learning ability. At ordinary times, we should be diligent in thinking about working methods and skills and expand our thinking. We should be optimistic and positive to face the problems in our work. Work enthusiastically.

2020

has passed, and the 2021 is coming soon. The new year has a new goal. As long as we work hard and focus on optimism, I believe the sales volume will definitely get better and better.

Xu Zihan

sales work, both ups and downs, thank the company very much, let me get exercise in recent years.

The most important thing is to learn carefully and serve customers attentively. When visiting the hospital, I will pay more attention to observation. Sometimes I find that they often look everywhere for the same thing. I will help take it there next time. This is a trivial matter for me. When I think about it, I will do it. However, the teachers in the hospital will think that I am very careful and trustworthy. At ordinary times, I will send more messages to customers when I am free. Some words cannot be expressed in words. It will be better to express them in words. Holiday greetings and a message may have unexpected results. Just like Christmas, I sent a message to all my customers. Although only 30% of them gave me a message back, I was satisfied.

In the past few years of work, I have experienced losses, regrets, and gains and enrichment... For the new year, I still have dreams in my heart. If the policy allows, Les has to be able to Get better and better, and other products can be made slowly. In the new year, I hope that with the support of the leadership, we can go to the next level, not be at a loss for the current difficulties, and believe that our efforts can create a brilliant tomorrow.

Zheng Jie

Looking back on 2020, I experienced epidemic situation, drug withdrawal, limited amount and other events, and I felt a lot of emotion in my heart.

In particular, the implementation of amlodipine band procurement in 2020, under the impact of the primary completion of hospitals with similar varieties of band volume, coupled with the new crown epidemic led to the national home epidemic prevention, the sales of Rest has dropped sharply, and some hospitals even stopped the procurement of Rest first. However, I still maintain a high frequency of contact with customers, learned that they are in the front line of the epidemic, a mask to use two days, I began to trust various relationships to buy masks, masks sent to the hands of doctors, to do something to fight the epidemic. When doctors received masks, they laughed and said they were the most useful gift in life. I also participated in the volunteer service of the hospital, and went door-to-door with them to fill in the personnel information form. Through such efforts, I finally got the praise of the hospital leaders and restored the prescription of Ristek.

June is the time to fill in the volunteer form for the college entrance examination. The hospital I maintain has 12 doctors' children who need to fill in the volunteer form. Usually, I pay more attention to the details of voluntary reporting. When I provide them with accurate and reasonable suggestions, I suddenly become their voluntary reporting consultant. I used the rest time to communicate with the examinees. According to their thoughts, learning ability and personality, I constantly revised dozens of filling plans. From the choice of school and major to the ranking of school volunteers, I gave reasonable suggestions. When their children received the admission notice of their favorite school, the trust of customers in me increased to a higher level, at the same time, it also completed the conversion from business to friends, to enhance their loyalty to the company's varieties. First of all, do a good job of people and get their recognition, and they will transfer this recognition to the product, which will turn into support for my work.

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页